ST Elevation Myocardial Infarction
"ST Elevation Myocardial Infarction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION).
| Descriptor ID |
D000072657
|
| MeSH Number(s) |
C14.280.647.500.875 C14.907.585.500.875
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "ST Elevation Myocardial Infarction".
Below are MeSH descriptors whose meaning is more specific than "ST Elevation Myocardial Infarction".
This graph shows the total number of publications written about "ST Elevation Myocardial Infarction" by people in this website by year, and whether "ST Elevation Myocardial Infarction" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2016 | 4 | 0 | 4 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 1 | 3 |
| 2020 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "ST Elevation Myocardial Infarction" by people in Profiles.
-
Synthetic cannabinoids and ST elevation myocardial infarction. Am J Med Sci. 2022 Oct; 364(4):481-491.
-
Impact of Early (=24 h) Versus Delayed (>24 h) Intervention in Patients With Non-ST Segment Elevation Myocardial Infarction: An Observational Study of 20,882 Patients From the London Heart Attack Group. Cardiovasc Revasc Med. 2021 01; 22:3-7.
-
Early vs Late Discharge in Low-Risk ST-Elevation Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2020 11; 21(11):1360-1368.
-
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry. J Thromb Thrombolysis. 2019 Jul; 48(1):42-51.
-
Interaction Between Ticagrelor and CYP3A4 Inhibitor: Importance of P2Y12 Function Testing to Assess Platelet Recovery Before Surgery. J Cardiothorac Vasc Anesth. 2019 11; 33(11):3221-3222.
-
An analysis of randomized controlled trials underpinning ST-elevation myocardial infarction management guidelines. Am J Emerg Med. 2019 12; 37(12):2229-2238.
-
Early Readmissions After ST-Segment-Elevation Myocardial Infarction: Glass Ceiling or Room for Improvement? J Am Heart Assoc. 2018 09 18; 7(18):e010506.
-
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention: Results from a large single-center prospective registry. Am Heart J. 2019 01; 207:10-18.
-
Prognostic Relation Between Severity of Diabetes Mellitus (On or Off Insulin)?±?Chronic Kidney Disease with Cardiovascular Risk After Percutaneous Coronary Intervention. Am J Cardiol. 2018 01 15; 121(2):168-176.
-
Asymptomatic Large Thrombus Formation in Drug-Eluting Stent 2 Days After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patient. JACC Cardiovasc Interv. 2017 12 11; 10(23):2461-2463.